SCHEMBL7298832

SCHEMBL7298832

O=C(Cc1ccccc1)Nc1ccccc1OCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.70
▸ GAA P10253 2/20 0.68
▸ KMT2A Q03164 4/20 0.63
▸ L3MBTL1 Q9Y468 3/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ MEN1 O00255 2/20 0.59
▸ HPGD P15428 3/20 0.58
▸ ALDH1A1 P00352 5/20 0.56
▸ PPIA P62937 2/20 0.55
▸ EPHX2 P34913 1/20 0.53
▸ LMNA P02545 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ SGMS2 Q8NHU3 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7935581 0.86 BRD4 (0.68) BRD4GAAKMT2AL3MBTL1TDP1
SCHEMBL13652590 0.86 BRD4 (0.73) BRD4GAAKMT2AL3MBTL1TDP1
SCHEMBL5174575 0.86 BRD4 (0.68) BRD4GAAKMT2AL3MBTL1TDP1
SCHEMBL3619403 0.85 BRD4 (0.77) BRD4GAAL3MBTL1TDP1PPIA
SCHEMBL4297414 0.84 BRD4 (0.74) BRD4GAAL3MBTL1TDP1ALDH1A1
SCHEMBL6169172 0.83 MEN1 (0.83) GAAKMT2AL3MBTL1MEN1HPGD
SCHEMBL8924076 0.83 BRD4 (1.00) BRD4KMT2AL3MBTL1TDP1MEN1
SCHEMBL18051152 0.81 BRD4 (0.66) BRD4GAAKMT2AL3MBTL1TDP1
SCHEMBL11549645 0.81 BRD4 (0.70) BRD4GAAKMT2AL3MBTL1TDP1
SCHEMBL38660185 0.81 BRD4 (0.70) BRD4GAAKMT2AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 — — US disclosed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 — — EP disclosed
Send feedback